Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Biomolecules|October 27, 2022
Insight on the Role of Leptin: A Bridge from Obesity to Breast CancerRoberto Buonaiuto, Fabiana Napolitano, Sara Parola, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 13, 2026
DNA hydroxymethylation of NCX1 heart promoter by GATA6/TET3 epigenetic complex participates in neuroprotection induced by hypoxic preconditioningNatascia Guida, Silvia Ruggiero, Angelo Serani, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 8, 2019
HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damageLuigi Formisano, Giusy Laudati, Natascia Guida, et al.
Melanoma Research|June 16, 2026
Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanomaMarcella Scala, David Lorente-Estellés, Luigi Liguori, et al.
Targeted Oncology|April 17, 2025
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled TrialsGiada Pinterpe, Fortuna Migliaccio, Chiara Ciccarese, et al.
Journal of the American Heart Association|March 8, 2024
Stroke Causes DNA Methylation at Ncx1 Heart Promoter in the Brain Via DNMT1/MeCP2/REST Epigenetic ComplexNatascia Guida, Angelo Serani, Luca Sanguigno, et al.
Neurobiology of Disease|August 19, 2021
Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse modelSerenella Anzilotti, Valeria Valsecchi, Paola Brancaccio, et al.
Neurochemistry International|April 4, 2025
Sp4/HD11 and Sp1/HAT-p300 complexes induce apoptotic cell death in CuCl2-treated neurons by modulating histone acetylation on BCL-W and BAX promotersSilvia Ruggiero, Natascia Guida, Luigi Mascolo, et al.
Future Oncology (London, England)|May 24, 2022
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational studyAlberto Servetto, Antonio Santaniello, Fabiana Napolitano, et al.
NPJ Breast Cancer|May 31, 2023
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancerStefania Belli, Daniela Esposito, Alessandra Allotta, et al.
Pageof 18